Cryptosporidiosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
* '''Medical Therapy''' | * '''Medical Therapy''' | ||
::* '''1. Immunocompetent'''<ref name="pmid11398117">{{cite journal| author=Rossignol JF, Ayoub A, Ayers MS| title=Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. | journal=J Infect Dis | year= 2001 | volume= 184 | issue= 1 | pages= 103-6 | pmid=11398117 | doi=10.1086/321008 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11398117 }} </ref> | |||
:::* Preferred regimen: No specific therapy recommended since healthy patients usually recover within a few weeks, but if needed: [[Nitazoxanide]] 500 mg PO bid for 3 days. | |||
::* '''2. HIV'''<ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2015 | isbn = 978-1930808843 }}</ref> | |||
:::* Preferred regimen: [[Nitazoxanide]] 500 mg PO bid for 3 days | |||
::* '''3. HIV and Immunodeficiency'''<ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2015 | isbn = 978-1930808843 }}</ref> | |||
:::* Preferred regimen: Effective antiretroviral therapy | |||
:::* Note: Nitazoxanide is not licensed for immunodeficient patients | |||
==External Link== | ==External Link== | ||
http://www.cdc.gov/parasites/crypto/treatment.html | http://www.cdc.gov/parasites/crypto/treatment.html | ||
Revision as of 17:47, 7 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
|
Cryptosporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptosporidiosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Cryptosporidiosis medical therapy |
|
Risk calculators and risk factors for Cryptosporidiosis medical therapy |
Medical Therapy
- Supportive care:
- Diarrhea can be managed by drinking plenty of fluids to prevent dehydration. People who are in poor health or who have weakened immune systems are at higher risk for more severe and prolonged illness. Young children and pregnant women may be more susceptible to dehydration resulting from diarrhea and should drink plenty of fluids while ill. Rapid loss of fluids from diarrhea may be especially life threatening to babies. Therefore, parents should talk to their health care providers about fluid replacement therapy options for infants.
- Anti-diarrheal medicine may help slow down diarrhea, but a health care provider should be consulted before such medicine is taken. Nitazoxanide has been FDA-approved for treatment of diarrhea caused by Cryptosporidium in people with healthy immune systems and is available by prescription. However, the effectiveness of nitazoxanide in immunosuppressed individuals is unclear.
- HIV-positive individuals who suspect they have cryptosporidiosis should contact their health care provider. For those persons with AIDS, anti retroviral therapy that improves the immune status will also decrease or eliminate symptoms of cryptosporidiosis. However, even if symptoms disappear, cryptosporidiosis is often not curable and the symptoms may return if the immune status worsens.
- Medical Therapy
- 1. Immunocompetent[1]
- Preferred regimen: No specific therapy recommended since healthy patients usually recover within a few weeks, but if needed: Nitazoxanide 500 mg PO bid for 3 days.
- 2. HIV[2]
- Preferred regimen: Nitazoxanide 500 mg PO bid for 3 days
- 3. HIV and Immunodeficiency[3]
- Preferred regimen: Effective antiretroviral therapy
- Note: Nitazoxanide is not licensed for immunodeficient patients
External Link
http://www.cdc.gov/parasites/crypto/treatment.html
References
- ↑ Rossignol JF, Ayoub A, Ayers MS (2001). "Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide". J Infect Dis. 184 (1): 103–6. doi:10.1086/321008. PMID 11398117.
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.